• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problems Ischemia (1942); Occlusion (1984)
Event Date 03/27/2019
Event Type  Injury  
Manufacturer Narrative
Since no patient id is available, the gore event number was used as the patient identifier.The patient age and patient gender reflects the mean age and gender stated in the article.The date of online publication was used as the event date.Lot/serial numbers were not provided, therefore, a review of the manufacturing records could not be conducted.
 
Event Description
The following publication was reviewed: ¿long-term results of the heparin-bonded viabahn stent graft in femoropopliteal tasc c and d lesions with a covered stent length of minimum 25 cm¿ (c.Uhl et.Al, vacular, 2019, published online 27-mar-2019).The article analyzed the outcome of 62 patients that presented with femoropopliteal tasc c or d lesions that were treated with gore viabahn® endoprostheses with a minimum length of 25cm between july 2010 and march 2018.It was also stated that in 37 cases, one stent graft was used, and in the other 23 cases more than one stent graft was necessary.The used stent diameter was between 5 mm and 8 mm.The article includes the following case: for one patient an early occlusion occurred (<30days) in which the patient underwent major amputation without further revascularization treatment.Indication in this case was critical limb ischemia in a patient additionally suffering from a bowel cancer under palliative care.Because of the high intestinal bleeding risk, a lysis was not feasible to treat the graft occlusion.Autologous vein was also not available in this patient.Due to the increasing necrosis of the foot, we decided for major amputation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
joerg kersten
1500 n. 4th street
9285263030
MDR Report Key9108776
MDR Text Key161512936
Report Number2017233-2019-00892
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 09/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-